New treatment targets natural tears for dry eyes

RESTASIS®1 is Now Approved by Health Canada for the Treatment of Dry Eye Disease

TORONTO, Nov. 25 /PRNewswire/ - To view this Social Media Release, please enter the following address in your web browser.

http://smr.newswire.ca/en/allergan-inc/new-treatment-targets-natural-tears-for-dry-eyes

/NOTE TO PHOTO EDITORS: Photos accompanying this release are also available at http://photos.newswire.ca. Images are free to accredited members of the media/

SOURCE Allergan Inc.

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.